Erratum to Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)
Erratum

Erratum to Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)

doi: 10.21037/tlcr.2020.03.39


Erratum to: Transl Lung Cancer Res 2019;8:1163-73


Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)

In the article that appeared on Page 1163-1173, Vol 8, No 6 (December 2019) Issue of the Translational Lung Cancer Research (1), the spelling of the author’s name “Ganning Jiang” should be corrected as “Gening Jiang”.

The publisher regrets the error.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Liang W, Cai K, Chen C, et al. Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition). Transl Lung Cancer Res 2019;8:1163-73. [Crossref] [PubMed]
Cite this article as: Erratum to Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition). Transl Lung Cancer Res 2020;9(3):944. doi: 10.21037/tlcr.2020.03.39